Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decorin in sub scleral trabeculectomy
NCT03924544Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of decorin in primary open-angle glaucoma (POAG), sponsored by Cairo University. Primary endpoint: Success of trabeculectomy at 1 year. Status: unknown.
02
Drugs
decorin
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT03924544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03924544.